| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
I Physiologisches Institut, Universität Heidelberg, Germany.
1. The effects of locally applied parathyroid hormone-related protein (PTHRP), a putative autocrine/paracrine hormone, on vascular diameters and glomerular blood flow (GBF) in the split hydronephrotic rat kidney were studied. As PTHRP interacts with parathyroid hormone (PTH) receptors in all tissues tested so far, the effects of PTHRP were compared with those of PTH. 2. Preglomerular vessels dilated in a concentration- and time-dependent manner that was almost identical for PTH and PTHRP. A significant preglomerular vasodilation (5-17%) occurred at a threshold concentration of 10(-10) mol l-1 PTH or PTHRP, which raised GBF by 20 +/- 2 and 31 +/- 4%, respectively (means +/- S.E.M., n = 6). PTH or PTHRP (10(-7) mol l-1) increased preglomerular diameters (11-36%) and GBF (60 +/- 10 and 70 +/- 8%, respectively) to near maximum. The most prominent dilatation was located at the interlobular artery and at the proximal afferent arteriole. 3. Efferent arterioles were not affected by either PTH or PTHRP. 4. Estimated concentrations of half-maximal response (EC50) for preglomerular vasodilatation and GBF increase were in the nanomolar to subnanomolar range. 5. After inhibition of angiotensin I-converting enzyme by 2 x 10(-6) mol kg-1 quinapril I.V. (n = 6), 10(-8) mol l-1 PTHRP dilated preglomerular vessels and efferent arterioles (9 +/- 1% proximal and 6 +/- 1% distal). 6. We conclude that the renal vasculature of the hydronephrotic kidney is highly sensitive to vasodilatation by PTH and PTHRP, which, in addition, may constrict efferent arterioles by stimulating renin release.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al. Bone disease after renal transplantation Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458. [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Noonan, J. Qian, W. D. Stuart, T. L. Clemens, and J. N. Lorenz Altered Renal Hemodynamics in Mice Overexpressing the Parathyroid Hormone (PTH)/PTH-Related Peptide Type 1 Receptor in Smooth Muscle Endocrinology, November 1, 2003; 144(11): 4931 - 4938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ogata, E. Ritz, G. Odoni, K. Amann, and S. R. Orth Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors J. Am. Soc. Nephrol., April 1, 2003; 14(4): 959 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Funk, E. Migliati, G. Chen, H. Wei, J. Wilson, K. J. Downey, P. J. Mullarky, B. M. Coull, P. F. McDonagh, and L. S. Ritter Parathyroid hormone-related protein induction in focal stroke: a neuroprotective vascular peptide Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1021 - R1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Eichinger, N. Fiaschi-Taesch, T. Massfelder, S. Fritsch, M. Barthelmebs, and J.-J. Helwig Transcript Expression of the Tuberoinfundibular Peptide (TIP)39/PTH2 Receptor System and Non-PTH1 Receptor-Mediated Tonic Effects of TIP39 and Other PTH2 Receptor Ligands in Renal Vessels Endocrinology, August 1, 2002; 143(8): 3036 - 3043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamamoto, I. Morimoto, Y. Tanaka, N. Yanagihara, and S. Eto The Mutual Regulation of Arginine-Vasopressin and PTHrP Secretion in Dissociated Supraoptic Neurons Endocrinology, April 1, 2002; 143(4): 1521 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. MASSFELDER, N. TAESCH, N. ENDLICH, A. EICHINGER, B. ESCANDE, K. ENDLICH, M. BARTHELMEBS, and J.-J. HELWIG Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension FASEB J, March 1, 2001; 15(3): 707 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Bosch, P. Rojo-Linares, G. Torrecillas-Casamayor, M. C. Iglesias-Cruz, D. Rodriguez-Puyol, and M. Rodriguez-Puyol Effects of parathyroid hormone-related protein on human mesangial cells in culture Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E990 - E995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamamoto, I. Morimoto, K. Zeki, Y. Ueta, H. Yamashita, H. Kannan, and S. Eto Centrally Administered Parathyroid Hormone (PTH)-Related Protein(1-34) But Not PTH(1-34) Stimulates Arginine-Vasopressin Secretion and Its Messenger Ribonucleic Acid Expression in Supraoptic Nucleus of the Conscious Rats Endocrinology, January 1, 1998; 139(1): 383 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-D. Schluter and H. M. Piper Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide Cardiovasc Res, January 1, 1998; 37(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wolzt, L. Schmetterer, G. Dorner, G. Zelger, J. Entlicher, S. Kapiotis, and H.-G. Eichler Hemodynamic Effects of Parathyroid Hormone-Related Peptide-(1-34) in Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2548 - 2551. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
